Last updated: June 16, 2021
Sponsor: Shanghai East Hospital
Overall Status: Active - Recruiting
Phase
1/2
Condition
Myocardial Ischemia
Heart Failure
Congestive Heart Failure
Treatment
N/AClinical Study ID
NCT04939077
MR-31-20-000323
Ages < 70 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- The patients with coronary heart disease, the effect of drug treatment is not good,and the clinical manifestations of left ventricular insufficiency occur, EF<40%;
- Coronary angiography confirmed that there is a chronic occlusive disease of thecoronary artery, which is manifested as severe stenosis of single or multiple coronaryvessels (≥75%), or even complete occlusion;
- After the doctor explained the treatment process and possible toxic and side effects,he was willing to treat and agreed to cooperate in the observation of the efficacy.But patients can withdraw from clinical trials and long-term follow-up observation atany time and unconditionally;
- The patient has no mental illness and language dysfunction and can fully understandthe treatment method.
Exclusion
Exclusion Criteria:
- Does not meet the above selection criteria;
- Unable to sign the informed consent form, unable to comply with the agreed timetableof this study;
- There are reasons to suspect that the patient was forced to join the trial;
- Acute left ventricular insufficiency, cardiogenic shock;
- The patient has any infectious diseases (including bacterial and viral infections);
- Others who are clinically considered unsuitable for this treatment.
Study Design
Total Participants: 20
Study Start date:
November 27, 2019
Estimated Completion Date:
November 30, 2022
Study Description
Connect with a study center
Shanghai East Hospital, Shanghai Tongji University
Shanghai, Shanghai 200120
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.